Lucent Diagnostics, a brand of Quanterix (QTRX) Corporation, has introduced LucentAD Complete, a new multi-marker blood test designed to help detect Alzheimer’s Disease (AD) in a broader range of ...

Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in asymptomatic patients.

BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has introduced LucentAD Complete, a new multi-marker blood test designed to help detect ...

A combined blood test for cognitive decline has a 90% accuracy rate in determining whether memory loss is due to Alzheimer’s disease. Dr. Sanjay Gupta explains. When Penny Ashford’s father was ...

Share on Pinterest Blood tests may help detect some neurodegenerative diseases in the future. Patricio Nahuelhual/Getty Images Researchers have discovered a blood marker they say can help in ...

In memory clinics and in research cohorts, immunoassays for plasma markers can now distinguish people who have Alzheimer’s disease pathology with remarkable accuracy (see Part 7 of this series). How ...

These markers are most helpful when someone already has a diagnosed cancer — to track treatment response or detect recurrence ...

A new three-pronged blood test can highlight people with a nearly tripled risk for heart attack, a new study says. The test relies on three blood markers linked to heart disease: lipoprotein a [Lp(a)] ...

Please provide your email address to receive an email when new articles are posted on . Biomarker combinations improved detection of pancreatic cancer in a double-blind trial. A phase 3 investigation ...

Heart disease is the leading cause of death in the United States. Since researchers first established the link between diet, ...

Sri Jayadeva Institute of Cardiovascular Sciences and Research has installed an advanced blood test analyser, the Roche Cobas ...